🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseEfinopegdutide MASH data — my results so far Page 3

Efinopegdutide MASH data — my results so far

tony_orlando Sat, Oct 4, 2025 at 5:15 AM 11 replies 1,314 viewsPage 3 of 3
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Oct 5, 2025 at 4:34 PM#11
Dr.MetabolicMD said:
Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then…

Correct, and worth adding that it is reversible. Nothing being described here is a one-way door, which changes how cautious it is reasonable to be.

49 22Dr.ObesityLA, NurseKim_ATL, paul_denver and 46 others
Reply Quote Save Share Report
SleepFixSam
Member
212
678
Nov 2024
Hawaii
Oct 6, 2025 at 10:12 PM#12
FranDenver said:
Liver imaging follow-up for liver and MASH: FibroScan at baseline showed CAP score 312 dB/m (moderate steatosis) and stiffness 8.8 kPa (possible…

Thank you for spelling out the reasoning rather than just the conclusion. I will report back once I have actually tried it.

Last edited: Oct 7, 2025 at 12:12 AM
50 23ingrid_STO, pete_nash, hank_denver and 47 others
Reply Quote Save Share Report
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
Oct 8, 2025 at 3:50 AM#13
Dr.MetabolicMD said:
Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then…

I do not accept the framing. The question has been narrowed to the version that has a tidy answer, and the part that was dropped is the part the OP actually asked about.

1 24paul_denver
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Oct 9, 2025 at 9:27 AM#14

Adding the numbers, since they settle part of this. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

2 0KarenAZ_mom, zoe_NC
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Oct 10, 2025 at 3:03 PM#15

Moderator note: a couple of off-topic posts removed. No action needed from anybody.

Last edited: Oct 10, 2025 at 7:03 PM
3 1PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register